Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Guanylyl cyclase domain-containing protein 1 (GUCD1) is a human protein encoded by the GUCD1 gene and is predicted to participate in biological processes such as liver regeneration and cAMP response, according to gene resource annotations[2]. While its nomenclature suggests a guanylyl cyclase function, studies indicate that GUCD1 lacks the functional domain that confers enzymatic cyclase activity seen in canonical guanylyl cyclases. Instead, it may play other, less well-defined roles in signaling pathways, and has been observed to interact with proteins such as NEDD4-1, potentially impacting cell growth regulation and tumor suppression[1][2]. GUCD1 is not recognized as a therapeutic target, and there is no evidence supporting its role as a receptor, enzyme, transporter, or drug target in current clinical or pharmacological practice[2][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Guanylyl cyclase domain-containing protein 1 (GUCD1).